Menu
GWAS Study

Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations.

Mancikova V, Cruz R, Inglada-Pérez L et al.

25855579 PubMed ID
GWAS Study Type
4230 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MV
Mancikova V
CR
Cruz R
IL
Inglada-Pérez L
FC
Fernández-Rozadilla C
LI
Landa I
CJ
Cameselle-Teijeiro J
CC
Celeiro C
PS
Pastor S
VA
Velázquez A
MR
Marcos R
AV
Andía V
ÁC
Álvarez-Escolá C
MA
Meoro A
SF
Schiavi F
OG
Opocher G
QI
Quintela I
AJ
Ansede-Bermejo J
RC
Ruiz-Ponte C
SP
Santisteban P
RM
Robledo M
CA
Carracedo A
Chapter II

Abstract

Summary of the research findings

Thyroid cancer is the most heritable cancer of all those not displaying typical Mendelian inheritance. However, most of the genetic factors that would explain the high heritability remain unknown. Our aim was to identify additional common genetic variants associated with susceptibility to this disease. In order to do so, we performed a genome-wide association study in a series of 398 cases and 502 controls from Spain, followed by a replication in four well-defined Southern European case-control collections contributing a total of 1,422 cases and 1,908 controls. The association between the variation at the 9q22 locus near FOXE1 and thyroid cancer risk was consistent across all series, with several SNPs identified (rs7028661: OR = 1.64, p = 1.0 × 10(-22) , rs7037324: OR = 1.54, p = 1.2 × 10(-17) ). Moreover, the rare alleles of three SNPs (rs2997312, rs10788123 and rs1254167) at 10q26.12 showed suggestive evidence of association with higher risk of the disease (OR = 1.35, p = 1.2 × 10(-04) , OR = 1.26, p = 5.2 × 10(-04) and OR = 1.38, p = 5.9 × 10(-05) , respectively). Finally, the rare allele of rs4075570 at 6q14.1 conferred protection in the series studied (OR = 0.82, p = 2.0 × 10(-04) ). This study suggests that heterogeneity in genetic susceptibility between populations is a key feature to take into account when exploring genetic risk factors related to this disease.

398 European ancestry cases , 502 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

4230
Total Participants
GWAS
Study Type
Yes
Replicated
1,422 European ancestry cases, 1,908 European ancestry controls
Replication Participants
European
Ancestry
Italy, Spain
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.